Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 215

1.

Encore - Sex dependency of the proteome.

Miller I, Gianazza E, Eberini I.

J Proteomics. 2020 Feb 10;212:103579. doi: 10.1016/j.jprot.2019.103579. Epub 2019 Nov 12. No abstract available.

PMID:
31726108
2.

SLC6A14, a Pivotal Actor on Cancer Stage: When Function Meets Structure.

Palazzolo L, Paravicini C, Laurenzi T, Adobati S, Saporiti S, Guerrini U, Gianazza E, Indiveri C, Anderson CMH, Thwaites DT, Eberini I.

SLAS Discov. 2019 Oct;24(9):928-938. doi: 10.1177/2472555219867317. Epub 2019 Aug 2.

PMID:
31373846
3.

Pro-oxidant and pro-inflammatory effects of glycated albumin on cardiomyocytes.

Martinez Fernandez A, Regazzoni L, Brioschi M, Gianazza E, Agostoni P, Aldini G, Banfi C.

Free Radic Biol Med. 2019 Nov 20;144:245-255. doi: 10.1016/j.freeradbiomed.2019.06.023. Epub 2019 Jun 28.

4.

What if? Mouse proteomics after gene inactivation.

Gianazza E, Miller I, Guerrini U, Palazzolo L, Laurenzi T, Parravicini C, Eberini I.

J Proteomics. 2019 May 15;199:102-122. doi: 10.1016/j.jprot.2019.03.008. Epub 2019 Mar 13. Review.

PMID:
30876943
5.

Immature surfactant protein-B impairs the antioxidant capacity of HDL.

Banfi C, Brioschi M, Karjalainen MK, Huusko JM, Gianazza E, Agostoni P.

Int J Cardiol. 2019 Jun 15;285:53-58. doi: 10.1016/j.ijcard.2019.02.057. Epub 2019 Feb 27.

PMID:
30857841
6.

Lipoxidation in cardiovascular diseases.

Gianazza E, Brioschi M, Fernandez AM, Banfi C.

Redox Biol. 2019 May;23:101119. doi: 10.1016/j.redox.2019.101119. Epub 2019 Feb 25. Review.

7.

A proteomic approach to identify novel disease biomarkers in LCAT deficiency.

Simonelli S, Ossoli A, Banfi C, Pavanello C, Calabresi L, Gianazza E.

J Proteomics. 2019 Apr 30;198:113-118. doi: 10.1016/j.jprot.2018.12.005. Epub 2018 Dec 6.

8.

In silico Description of LAT1 Transport Mechanism at an Atomistic Level.

Palazzolo L, Parravicini C, Laurenzi T, Guerrini U, Indiveri C, Gianazza E, Eberini I.

Front Chem. 2018 Aug 24;6:350. doi: 10.3389/fchem.2018.00350. eCollection 2018.

9.

Post-translational quantitation by SRM/MRM: applications in cardiology.

Gianazza E, Banfi C.

Expert Rev Proteomics. 2018 Jun;15(6):477-502. doi: 10.1080/14789450.2018.1484283. Review.

PMID:
29865883
10.

Editorial: A matter of ingredients.

Miller I, Gianazza E, Eberini I.

J Proteomics. 2018 Apr 30;178:1-6. doi: 10.1016/j.jprot.2018.03.019. Epub 2018 Mar 24. No abstract available.

PMID:
29581062
11.

In vitro assessment of silver nanoparticles immunotoxicity.

Galbiati V, Cornaghi L, Gianazza E, Potenza MA, Donetti E, Marinovich M, Corsini E.

Food Chem Toxicol. 2018 Feb;112:363-374. doi: 10.1016/j.fct.2017.12.023. Epub 2018 Jan 10.

PMID:
29331734
12.

Bacterial Production, Characterization and Protein Modeling of a Novel Monofuctional Isoform of FAD Synthase in Humans: An Emergency Protein?

Leone P, Galluccio M, Barbiroli A, Eberini I, Tolomeo M, Vrenna F, Gianazza E, Iametti S, Bonomi F, Indiveri C, Barile M.

Molecules. 2018 Jan 6;23(1). pii: E116. doi: 10.3390/molecules23010116.

13.

Gender proteomics I. Which proteins in non-sexual organs.

Gianazza E, Miller I, Guerrini U, Palazzolo L, Parravicini C, Eberini I.

J Proteomics. 2018 Apr 30;178:7-17. doi: 10.1016/j.jprot.2017.10.002. Epub 2017 Oct 6. Review.

PMID:
28988882
14.

Gender proteomics II. Which proteins in sexual organs.

Gianazza E, Miller I, Guerrini U, Palazzolo L, Parravicini C, Eberini I.

J Proteomics. 2018 Apr 30;178:18-30. doi: 10.1016/j.jprot.2017.10.001. Epub 2017 Oct 6.

PMID:
28988880
15.

Serum Proteome in a Sporadic Amyotrophic Lateral Sclerosis Geographical Cluster.

De Benedetti S, Gianazza E, Banfi C, Marocchi A, Lunetta C, Penco S, Bonomi F, Iametti S.

Proteomics Clin Appl. 2017 Dec;11(11-12). doi: 10.1002/prca.201700043. Epub 2017 Sep 25.

PMID:
28799191
16.

Blood trace metals in a sporadic amyotrophic lateral sclerosis geographical cluster.

De Benedetti S, Lucchini G, Del Bò C, Deon V, Marocchi A, Penco S, Lunetta C, Gianazza E, Bonomi F, Iametti S.

Biometals. 2017 Jun;30(3):355-365. doi: 10.1007/s10534-017-0011-4. Epub 2017 Mar 23.

PMID:
28337565
17.

Technological advances and proteomic applications in drug discovery and target deconvolution: identification of the pleiotropic effects of statins.

Banfi C, Baetta R, Gianazza E, Tremoli E.

Drug Discov Today. 2017 Jun;22(6):848-869. doi: 10.1016/j.drudis.2017.03.001. Epub 2017 Mar 8. Review.

PMID:
28284830
18.

Normal human mitral valve proteome: A preliminary investigation by gel-based and gel-free proteomic approaches.

Brioschi M, Baetta R, Ghilardi S, Gianazza E, Guarino A, Parolari A, Polvani G, Tremoli E, Banfi C.

Electrophoresis. 2016 Oct;37(20):2633-2643. doi: 10.1002/elps.201600081. Epub 2016 Sep 7.

19.

With or without you - Proteomics with or without major plasma/serum proteins.

Gianazza E, Miller I, Palazzolo L, Parravicini C, Eberini I.

J Proteomics. 2016 May 17;140:62-80. doi: 10.1016/j.jprot.2016.04.002. Epub 2016 Apr 10. Review.

20.

A promiscuous recognition mechanism between GPR17 and SDF-1: Molecular insights.

Parravicini C, Daniele S, Palazzolo L, Trincavelli ML, Martini C, Zaratin P, Primi R, Coppolino G, Gianazza E, Abbracchio MP, Eberini I.

Cell Signal. 2016 Jun;28(6):631-42. doi: 10.1016/j.cellsig.2016.03.001. Epub 2016 Mar 10.

PMID:
26971834
21.

Enzymatic reduction of acetophenone derivatives with a benzil reductase from Pichia glucozyma (KRED1-Pglu): electronic and steric effects on activity and enantioselectivity.

Contente ML, Serra I, Palazzolo L, Parravicini C, Gianazza E, Eberini I, Pinto A, Guidi B, Molinari F, Romano D.

Org Biomol Chem. 2016 Apr 7;14(13):3404-8. doi: 10.1039/c6ob00047a. Epub 2016 Mar 8.

22.

In silico prediction and characterization of protein post-translational modifications.

Gianazza E, Parravicini C, Primi R, Miller I, Eberini I.

J Proteomics. 2016 Feb 16;134:65-75. doi: 10.1016/j.jprot.2015.09.026. Epub 2015 Oct 9.

PMID:
26436211
23.

Stereoselective reduction of aromatic ketones by a new ketoreductase from Pichia glucozyma.

Contente ML, Serra I, Brambilla M, Eberini I, Gianazza E, De Vitis V, Molinari F, Zambelli P, Romano D.

Appl Microbiol Biotechnol. 2016 Jan;100(1):193-201. doi: 10.1007/s00253-015-6961-y. Epub 2015 Sep 16.

PMID:
26377422
24.

All-Purpose Containers? Lipid-Binding Protein - Drug Interactions.

Beringhelli T, Gianazza E, Maggioni D, Scanu S, Parravicini C, Sensi C, Monaco HL, Eberini I.

PLoS One. 2015 Jul 13;10(7):e0132096. doi: 10.1371/journal.pone.0132096. eCollection 2015.

25.

The selected reaction monitoring/multiple reaction monitoring-based mass spectrometry approach for the accurate quantitation of proteins: clinical applications in the cardiovascular diseases.

Gianazza E, Tremoli E, Banfi C.

Expert Rev Proteomics. 2014 Dec;11(6):771-88. doi: 10.1586/14789450.2014.947966. Epub 2014 Sep 2. Review.

PMID:
25400095
26.

Urinary signatures of Renal Cell Carcinoma investigated by peptidomic approaches.

Chinello C, Cazzaniga M, De Sio G, Smith AJ, Gianazza E, Grasso A, Rocco F, Signorini S, Grasso M, Bosari S, Zoppis I, Dakna M, van der Burgt YE, Mauri G, Magni F.

PLoS One. 2014 Sep 9;9(9):e106684. doi: 10.1371/journal.pone.0106684. eCollection 2014.

27.

In between - Proteomics of dog biological fluids.

Miller I, Preßlmayer-Hartler A, Wait R, Hummel K, Sensi C, Eberini I, Razzazi-Fazeli E, Gianazza E.

J Proteomics. 2014 Jun 25;106:30-45. doi: 10.1016/j.jprot.2014.04.016. Epub 2014 Apr 22. Review.

PMID:
24768907
28.

Altered iron homeostasis in an animal model of hypertensive nephropathy: stroke-prone rats.

Gelosa P, Pignieri A, Gianazza E, Criniti S, Guerrini U, Cappellini MD, Banfi C, Tremoli E, Sironi L.

J Hypertens. 2013 Nov;31(11):2259-69. doi: 10.1097/HJH.0b013e3283642f3e.

PMID:
24029866
29.

MBNL142 and MBNL143 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases.

Botta A, Malena A, Tibaldi E, Rocchi L, Loro E, Pena E, Cenci L, Ambrosi E, Bellocchi MC, Pagano MA, Novelli G, Rossi G, Monaco HL, Gianazza E, Pantic B, Romeo V, Marin O, Brunati AM, Vergani L.

Cell Death Dis. 2013 Aug 15;4:e770. doi: 10.1038/cddis.2013.291.

30.

Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach.

Consonni S, Mainini V, Pizzardi A, Gianazza E, Chinello C, Locatelli A, Magni F.

Arch Gynecol Obstet. 2014 Feb;289(2):299-306. doi: 10.1007/s00404-013-2967-9. Epub 2013 Jul 20.

PMID:
23872981
31.

A proteomic portrait of atherosclerosis.

Eberini I, Wait R, Calabresi L, Sensi C, Miller I, Gianazza E.

J Proteomics. 2013 Apr 26;82:92-112. doi: 10.1016/j.jprot.2013.02.007. Epub 2013 Feb 19. Review.

PMID:
23435058
32.

Urinary exosomes and diabetic nephropathy: a proteomic approach.

Raimondo F, Corbetta S, Morosi L, Chinello C, Gianazza E, Castoldi G, Di Gioia C, Bombardi C, Stella A, Battaglia C, Bianchi C, Magni F, Pitto M.

Mol Biosyst. 2013 Jun;9(6):1139-46. doi: 10.1039/c2mb25396h.

PMID:
23344851
33.

Detection of high molecular weight proteins by MALDI imaging mass spectrometry.

Mainini V, Bovo G, Chinello C, Gianazza E, Grasso M, Cattoretti G, Magni F.

Mol Biosyst. 2013 Jun;9(6):1101-7. doi: 10.1039/c2mb25296a.

PMID:
23340489
34.

Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis.

Ornellas P, Ornellas AA, Chinello C, Gianazza E, Mainini V, Cazzaniga M, Pereira DA, Sandim V, Cypriano AS, Koifman L, Silva PC, Alves G, Magni F.

Int Braz J Urol. 2012 Nov-Dec;38(6):739-49.

35.

Inflammatory serum proteome pattern in mice fed a high-fat diet.

Gianazza E, Sensi C, Eberini I, Gilardi F, Giudici M, Crestani M.

Amino Acids. 2013 Mar;44(3):1001-8. doi: 10.1007/s00726-012-1433-5. Epub 2012 Dec 6.

PMID:
23224824
36.

Biosynthesis of flavin cofactors in man: implications in health and disease.

Barile M, Giancaspero TA, Brizio C, Panebianco C, Indiveri C, Galluccio M, Vergani L, Eberini I, Gianazza E.

Curr Pharm Des. 2013;19(14):2649-75. Review.

PMID:
23116402
37.

Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors.

Gianazza E, Chinello C, Mainini V, Cazzaniga M, Squeo V, Albo G, Signorini S, Di Pierro SS, Ferrero S, Nicolardi S, van der Burgt YE, Deelder AM, Magni F.

J Proteomics. 2012 Dec 5;76 Spec No.:125-40. doi: 10.1016/j.jprot.2012.07.032. Epub 2012 Jul 31.

PMID:
22868251
38.

Wards in the keyway: amino acids with anomalous pK(a)s in calycins.

Eberini I, Sensi C, Bovi M, Molinari H, Galliano M, Bonomi F, Iametti S, Gianazza E.

Amino Acids. 2012 Dec;43(6):2457-68. doi: 10.1007/s00726-012-1324-9. Epub 2012 May 30.

PMID:
22643844
39.

Proteomics of rat biological fluids--the tenth anniversary update.

Gianazza E, Wait R, Eberini I, Sensi C, Sironi L, Miller I.

J Proteomics. 2012 Jun 18;75(11):3113-28. doi: 10.1016/j.jprot.2012.03.053. Epub 2012 Apr 6. Review.

PMID:
22504499
40.

Silencing of FAD synthase gene in Caenorhabditis elegans upsets protein homeostasis and impacts on complex behavioral patterns.

Liuzzi VC, Giancaspero TA, Gianazza E, Banfi C, Barile M, De Giorgi C.

Biochim Biophys Acta. 2012 Apr;1820(4):521-31. doi: 10.1016/j.bbagen.2012.01.012. Epub 2012 Jan 28.

PMID:
22306247
41.

Severe high-density lipoprotein deficiency associated with autoantibodies against lecithin:cholesterol acyltransferase in non-Hodgkin lymphoma.

Simonelli S, Gianazza E, Mombelli G, Bondioli A, Ferraro G, Penco S, Sirtori CR, Franceschini G, Calabresi L.

Arch Intern Med. 2012 Jan 23;172(2):179-81. doi: 10.1001/archinternmed.2011.661.

PMID:
22271127
42.

Neglected markers: altered serum proteome in murine models of disease.

Gianazza E, Vegeto E, Eberini I, Sensi C, Miller I.

Proteomics. 2012 Feb;12(4-5):691-707. doi: 10.1002/pmic.201100320. Epub 2012 Jan 19. Review.

PMID:
22247026
43.

Modulation of urinary peptidome in humans exposed to high altitude hypoxia.

Mainini V, Gianazza E, Chinello C, Bilo G, Revera M, Giuliano A, Caldara G, Lombardi C, Piperno A, Magni F, Parati G.

Mol Biosyst. 2012 Apr;8(4):959-66. doi: 10.1039/c1mb05377a. Epub 2011 Dec 7.

PMID:
22146999
44.

Human FAD synthase (isoform 2): a component of the machinery that delivers FAD to apo-flavoproteins.

Torchetti EM, Bonomi F, Galluccio M, Gianazza E, Giancaspero TA, Iametti S, Indiveri C, Barile M.

FEBS J. 2011 Nov;278(22):4434-49. doi: 10.1111/j.1742-4658.2011.08368.x. Epub 2011 Oct 20.

45.

Simulation of urea-induced protein unfolding: a lesson from bovine β-lactoglobulin.

Eberini I, Emerson A, Sensi C, Ragona L, Ricchiuto P, Pedretti A, Gianazza E, Tramontano A.

J Mol Graph Model. 2011 Sep;30:24-30. doi: 10.1016/j.jmgm.2011.06.004. Epub 2011 Jun 13.

PMID:
21724434
46.

Electrostatics of folded and unfolded bovine β-lactoglobulin.

Eberini I, Sensi C, Barbiroli A, Bonomi F, Iametti S, Galliano M, Gianazza E.

Amino Acids. 2012 May;42(5):2019-30. doi: 10.1007/s00726-011-0933-z. Epub 2011 May 26.

PMID:
21614557
47.

Mutual information optimization for mass spectra data alignment.

Zoppis I, Gianazza E, Borsani M, Chinello C, Mainini V, Galbusera C, Ferrarese C, Galimberti G, Sorbi S, Borroni B, Magni F, Antoniotti M, Mauri G.

IEEE/ACM Trans Comput Biol Bioinform. 2012 May-Jun;9(3):934-9. doi: 10.1109/TCBB.2011.80. Epub 2011 Apr 19.

PMID:
21519116
48.

Energy matters: mitochondrial proteomics for biomedicine.

Gianazza E, Eberini I, Sensi C, Barile M, Vergani L, Vanoni MA.

Proteomics. 2011 Feb;11(4):657-74. doi: 10.1002/pmic.201000412. Epub 2011 Jan 17. Review.

PMID:
21241019
49.

Farm animal proteomics--a review.

Bendixen E, Danielsen M, Hollung K, Gianazza E, Miller I.

J Proteomics. 2011 Mar 1;74(3):282-93. doi: 10.1016/j.jprot.2010.11.005. Epub 2010 Nov 26. Review.

PMID:
21112346
50.

Structural and dynamic features of apolipoprotein A-I cysteine mutants, Milano and Paris, in synthetic HDL.

Rocco AG, Sensi C, Gianazza E, Calabresi L, Franceschini G, Sirtori CR, Eberini I.

J Mol Graph Model. 2010 Nov;29(3):406-14. doi: 10.1016/j.jmgm.2010.08.002. Epub 2010 Aug 20.

PMID:
20869895

Supplemental Content

Loading ...
Support Center